Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,967 JPY | +1.44% | +3.70% | +25.77% |
Feb. 21 | Japanese Shares Slump for Second Day After Business Sentiment Data | MT |
Feb. 21 | Espec's Nine-Month Attributable Profit Nearly Doubles as Orders Reach All-Time High | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+25.77% | 408M | - | ||
+12.53% | 83.13B | A- | ||
+20.35% | 71.2B | B | ||
+20.75% | 37.69B | B- | ||
+15.94% | 32.06B | A | ||
+11.57% | 27.33B | B- | ||
+4.58% | 27.11B | C+ | ||
+3.90% | 26.01B | B+ | ||
+17.36% | 24.71B | B+ | ||
+17.05% | 24.74B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 6859 Stock
- Ratings Espec Corp.